stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Veracyte IncVCYT
$23.951.56%-0.38

Veracyte Inc (VCYT)

Veracyte Inc stock is traded at $23.95, with a volume of 146,163. It is down -1.56% in the last 24 hours and down -44.46% over the past month. Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Previous Close:
$24.33
Open:
$23.97
24h Volume:
146,163
Relative Volume:
0.03
Market Cap:
$1.93B
Revenue:
$541.74M
Net Income/Loss:
$88.01M
P/E Ratio:
22.05
EPS:
$1.09
Net Cash Flow:
$155.34M
1W Performance:
-7.60%
1M Performance:
-44.46%
6M Performance:
-37.76%
1Y Performance:
-39.14%
1-Day Range:
$23.27$24.10
1-Week Range:
$23.27$25.88
52-Week Range:
$21.91$60.91

Veracyte Inc Stock (VCYT) Company Profile

Name
Veracyte Inc
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, USA
Employee
755
Next Earnings Date
-
Latest SEC Filings
SEC
VCYT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Veracyte Inc Stock (VCYT) Financials Data

Similar to VCYT